|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang XF, Qi X, Meng B, Liu C, Yu L, Wang
B and Lv Y: Prognosis evaluation in alpha-fetoprotein negative
hepatocellular carcinoma after hepatectomy: Comparison of five
staging systems. Eur J Surg Oncol. 36:718–724. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Amarapurkar D, Han KH, Chan HL and Ueno Y;
Asia-Pacific Working Party on Prevention of Hepatocellular C, :
Application of surveillance programs for hepatocellular carcinoma
in the Asia-Pacific Region. J Gastroenterol Hepatol. 24:955–961.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lai EC and Lau WY: The continuing
challenge of hepatic cancer in Asia. Surgeon. 3:210–215. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lau WY, Lai EC, Leung TW and Yu SC:
Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable
hepatocellular carcinoma: A prospective randomized trial-update on
5-year and 10-year survival. Ann Surg. 247:43–48. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cucchetti A, Zanello M, Cescon M, Ercolani
G, Del Gaudio M, Ravaioli M, Grazi GL and Pinna AD: Improved
diagnostic imaging and interventional therapies prolong survival
after resection for hepatocellular carcinoma in cirrhosis: The
university of bologna experience over 10 years. Ann Surg Oncol.
18:1630–1637. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie H, Wang H, An W, Ma W, Qi R, Yang B,
Liu C, Gao Y, Xu B and Wang W: The efficacy of radiofrequency
ablation combined with transcatheter arterial chemoembolization for
primary hepatocellular carcinoma in a cohort of 487 patients. PLoS
One. 9:e890812014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin Z, Ren Z and Xia J: Appraisal of
postoperative transcatheter arterial chemoembolization (TACE) for
prevention and treatment of hepatocellular carcinoma recurrence.
Zhonghua Zhong Liu Za Zhi. 22:315–317. 2000.(In Chinese).
PubMed/NCBI
|
|
10
|
Lee JK, Chung YH, Song BC, Shin JW, Choi
WB, Yang SH, Yoon HK, Sung KB, Lee YS and Suh DJ: Recurrences of
hepatocellular carcinoma following initial remission by
transcatheter arterial chemoembolization. J Gastroenterol Hepatol.
17:52–58. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Portolani N, Coniglio A, Ghidoni S,
Giovanelli M, Benetti A, Tiberio GA and Giulini SM: Early and late
recurrence after liver resection for hepatocellular carcinoma:
Prognostic and therapeutic implications. Ann Surg. 243:229–235.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Samuel M, Chow PK, Chan Shih-Yen E, Machin
D and Soo KC: Neoadjuvant and adjuvant therapy for surgical
resection of hepatocellular carcinoma. Cochrane Database Syst Rev.
21:CD0011992009.
|
|
13
|
Association HBaIDBoCM: Guidelines for
prevention and treatment of chronic hepatitis B (2010 Edition).
Chin J Hepatology Electronic Edition. 3:40–56. 2011.
|
|
14
|
Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH,
Wang L, Ren N, Zhuang PY, Zhu XD, Fan J and Tang ZY: Positive serum
hepatitis B e antigen is associated with higher risk of early
recurrence and poorer survival in patients after curative resection
of hepatitis B-related hepatocellular carcinoma. J Hepatol.
12:684–690. 2007. View Article : Google Scholar
|
|
15
|
Roayaie S, Blume IN, Thung SN, Guido M,
Fiel MI, Hiotis S, Labow DM, Llovet JM and Schwartz ME: A system of
classifying microvascular invasion to predict outcome after
resection in patients with hepatocellular carcinoma.
Gastroenterology. 137:850–855. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ardiles V, Sánchez Clariá R, Mazza OM,
Ciardullo MA, Pekolj J and De Santibañes E: Prognostic factors
after resection of hepatocellular carcinoma in the non-cirrhotic
liver: Presentation of 51 cases. Cir Esp. 87:148–154. 2010.(In
Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sumie S, Kuromatsu R, Okuda K, Ando E,
Takata A, Fukushima N, Watanabe Y, Kojiro M and Sata M:
Microvascular invasion in patients with hepatocellular carcinoma
and its predictable clinicopathological factors. Ann Surg Oncol.
15:1375–1382. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tian YH, Li JD, Peng Y, Li QL, Li DX and
Li Q: Postoperative survival analysis of patients without liver
cirrhosis. Chin J Digestive Surg. 10:305–306. 2011.
|
|
19
|
Yamamoto J, Kosuge T, Takayama T, Shimada
K, Yamasaki S, Ozaki H, Yamaguchi N and Makuuchi M: Recurrence of
hepatocellular carcinoma after surgery. Br J Surg. 83:1219–1222.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Geschwind JF, Kudo M, Marrero JA, Venook
AP, Chen XP, Bronowicki JP, Dagher L, Furuse J, Ladrón de Guevara
L, Papandreou C, et al: TACE treatment in patients with
sorafenib-treated unresectable hepatocellular carcinoma in clinical
practice: Final analysis of GIDEON. Radiology. 279:630–640. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hua YF, Li CD, Qiu F, Yu WM, Wu SD, Zhang
GJ, Peng T and Yang HT: Transcatheter arterial chemoembolization
after liver resection for hepatocellular carcinoma with portal vein
tumor thrombus. Chin J Hepatobiliary Surg. 18:357–360. 2012.(In
Chinese).
|
|
22
|
Shah SA, Cleary SP, Wei AC, Yang I, Taylor
BR, Hemming AW, Langer B, Grant DR, Greig PD and Gallinger S:
Recurrence after liver resection for hepatocellular carcinoma: Risk
factors, treatment and outcomes. Surgery. 141:330–339. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsurusaki M and Murakami T: Surgical and
locoregional therapy of HCC: TACE. Liver Cancer. 4:165–175. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu Q, Qiao GL, Yan JJ, Wu MC and Yan YQ:
Prognosis after resection of early hepatocellular carcinoma in
HBV-related cirrhotic patients. Chin J Hepatobiliary Surg.
20:258–264. 2014.
|
|
25
|
Otto G, Heuschen U, Hofmann WJ, Krumm G,
Hinz U and Herfarth C: Survival and recurrence after liver
transplantation versus liver resection for hepatocellular
carcinoma: A retrospective analysis. Ann Surg. 227:424–432. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pawlik TM, Delman KA, Vauthey JN, Nagorney
DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT and
Abdalla EK: Tumor size predicts vascular invasion and histologic
grade: Implications for selection of surgical treatment for
hepatocellular carcinoma. Liver Transpl. 11:1086–1092. 2005.
View Article : Google Scholar : PubMed/NCBI
|
